Beyond LDL Cholesterol Reduction-Reference-Cited by-同舟云学术

Beyond LDL Cholesterol Reduction

Published:1996-11-15 Issue:10 Volume:94 Page:2351-2354
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Superko H. Robert¹

Affiliation:

1. Cholesterol, Genetics, and Heart Disease Institute and Berkeley HeartLab, San Mateo, and Lawrence Berkeley National Laboratory, Berkeley, Calif.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference29 articles.

1. New aspects of risk factors for the development of atherosclerosis, including small low-density lipoprotein, homocyst(e)ine, and lipoprotein(a)

2. Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease

3. Superko HR. Inherited disorders in the lipoprotein system: a common cause of premature heart disease. In: Julian DG Wenger NK eds. Women and Heart Disease. London UK: Martin Dunitz Ltd; 1996.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia;Schizophrenia Research;2023-12

2. Exploring the Association between Low-Density Lipoprotein Subfractions and Major Adverse Cardiovascular Outcomes—A Comprehensive Review;International Journal of Molecular Sciences;2023-04-03

3. Short- and Long-Term Biological Variability of Small Dense LDL, HDL3, and Triglyceride-Rich Lipoprotein Cholesterol;The Journal of Applied Laboratory Medicine;2022-07-28

4. Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options;Biomedicines;2021-10-29

5. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study;Scientific Reports;2021-05-10